Actress Kate Winslet lost her mother to ovarian cancer
A NEW drug has been approved in Scotland to treat a cancer that lags behind others in survival rates.
Rucaparib (Rubraca) was accepted for use on the NHS as a maintenance treatment in patients whose recurring ovarian cancer has responded partially or completely to treatment with chemotherapy.
Patients currently receive gruelling rounds of chemo with increasingly shorter time between relapses.
The new drug can be taken at home.
Two other treatments were approved by the Scottish Medicines Consortium (SMC) for non-small cell lung cancer and a rare form of acute lymphoblastic leukaemia.
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here